Dynavax (DVAX) Misses Q1 EPS by 81c, Misses on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail
Get Alerts DVAX Hot Sheet
Price: $15.50 --0%
Financial Fact:
General and administrative: 11.77M
Today's EPS Names:
SMXT, NRIX, VFS, More
Financial Fact:
General and administrative: 11.77M
Today's EPS Names:
SMXT, NRIX, VFS, More
Join SI Premium – FREE
Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.77), $0.81 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $65 million versus the consensus estimate of $67.86 million.
For earnings history and earnings-related data on Dynavax (DVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Starts SoFi Technologies (SOFI) at Buy
- Roth/MKM Downgrades NeuroSense Therapeutics Ltd. (NRSN) to Neutral
- S&P Dow Jones Indices launches joint index with HKEX
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
